iPlato (myGP)
iPlato (myGP) at a glanceiPlato (myGP) (Medical) has a unitQ Score of 73 out of 100, rated good, as the 30-day average on Nov 9, 2026, up 12 points from 61 in the previous 30 days. The score draws on 101 user feedback reports from the App Store and Google Play in the last 30 days. Top feedback themes: Difficult to Navigate UI, Unsatisfactory Behavior and Fails To Launch.
What’s unitQ Score? unitQ Score measures the gap between user expectations and their actual experience. It is an unbiased and proprietary machine-generated scoring algorithm that represents the percentage of a company's customers reporting a frictionless experience with their product or service.
unitQ Score 30 Day Average as of Nov 09, 2026 12 point score increase in the last 30 days
30-Day Trend
User Feedback
- iOS
- 46 % 46 Reports
- Android
- 54 % 55 Reports
Compared with similar apps
iPlato (myGP)73
Flo: Health & Period Tracker73
Motivation69
I am - Positive Affirmations66
Calm63
MyFitnessPal37- MyFitnessPal37
Fabulous30- PPeloton29
Headspace26
Top feedback themes
- ApplicationUser InterfaceDifficult to Navigate UI
- Customer Support & SuccessConductUnsatisfactory Behavior
- ApplicationStabilityFails To Launch
About iPlato (myGP)
What is iPlato (myGP)?
The iPlato (myGP) app is a digital healthcare platform that allows users to manage their medical appointments and access health services conveniently. It helps patients communicate with their healthcare providers and monitor their health information through an easy-to-use interface.
Is iPlato (myGP) safe?
The iPlato (myGP) app is designed with strong security measures, including encryption and NHS-certified protection, thus making it generally safe for users. However, risks exist for younger audiences due to data-sharing practices and potential exposure to sensitive personal information. It's important for parents to understand the app's functioning and privacy policies to mitigate these risks.
Who owns iPlato (myGP) app?
The iPlato (myGP) app is owned by Huma, following their acquisition of iPLATO Healthcare. This acquisition has allowed Huma to extend its reach to over 26 million patients with their patient engagement software.